Top Biotech Companies (3,704)
Diffuse Bio is a biotechnology company that leverages generative AI to design and engineer novel protein therapeutics. By developing foundational models and software platforms like DiffuseSandbox and RamaX, the company aims to transition protein design from slow wet-lab workflows to high-precision computational design. Their mission is to create new and useful proteins with unprecedented control and accuracy to accelerate the...
Vividion Therapeutics, Inc. is a biotechnology company focused on transforming the future of human health through the creation of highly selective small molecule medicines that drug traditionally inaccessible targets. The company is advancing a broad, diversified pipeline of multiple, selective small molecule therapeutics for highly sought-after disease-causing target proteins in oncology and immunology. The company’s cutting-edge platform was spun out...
AbCellera is breaking the barriers of conventional antibody drug discovery to bring better medicines to patients, sooner. AbCellera’s engine integrates expert teams, technology, and facilities with the data science and automation needed to propel antibody-based medicines from target to clinic in nearly every therapeutic area with precision and speed. AbCellera provides innovative biotechs and leading pharmaceutical companies with a competitive...
Aura Biosciences is a clinical-stage biotechnology company focused on developing precision therapies for solid tumors that aim to preserve organ function. Our lead candidate, bel-sar (AU-011), is currently in late-stage development for early choroidal melanoma and in early-stage development in other ocular oncology indications and bladder cancer. Aura Biosciences is headquartered in Boston, MA. Our mission is to grow as...
Trans Ova Genetics is a livestock reproductive technology company that helps producers accelerate genetic progress and improve herd genetics. Its services include embryo transfer, in vitro fertilization (IVF), sexed semen, genetic preservation, cloning, donor housing, export, and recipient options. The company serves dairy and beef cattle, small ruminants, and swine, and operates as part of the URUS Group. Its mission...
Tr1X Inc. (pr. "Trix") is a biotechnology company dedicated to the development of novel cellular immunotherapies for patients with autoimmune and inflammatory diseases. The Company uses its proprietary platform for the generation of first-in-class cell therapy products aimed at rebalancing the immune system and restoring homeostasis, leading to long term tolerance. Tr1X is headquartered in La Jolla, CA.
Lucis focuses on Function Health for Europe, aiming to address preventable chronic diseases.
The Cancer Research Institute (CRI) is a New York City–based nonprofit organization dedicated to advancing cancer immunotherapy. Founded in 1953, it funds scientists and researchers, supports clinical-trial networks, and promotes global collaboration and shared data to accelerate discoveries from fundamental immunology through clinical translation. Its mission is to help turn breakthrough science into life-saving treatments and create a world immune...
Founded in 1997, Ergomed is a global provider of high-quality services to the biopharmaceutical industry, spanning all phases of clinical trials, post-approval pharmacovigilance, and medical information. Ergomed’s fast-growing services business includes an industry-leading suite of specialist pharmacovigilance (PV) solutions, integrated under the PrimeVigilance brand, and Ergomed Clinical Research, a complete, global Phase I-IV clinical development and trial management services with...
We develop AI and wet-lab technologies that enable the rational design of developable, selective, and functional drugs against previously undruggable targets. To maximize the patient impact of our platform, we collaborate with leading pharmaceutical companies, including AstraZeneca, Bristol Myers Squibb and Takeda, to expand their pipelines with high-quality drug candidates. If successful we could double the number of disease-relevant drug targets...
Endsulin, Inc. is a pre-clinical stage biotechnology company focused on developing a revolutionary liver-directed gene therapy to treat Type 1 Diabetes (T1DM). Its mission is to end insulin dependence for good and free patients from being defined by diabetes by delivering a patented genetic factor to the liver, restoring the body’s own ability to produce and regulate insulin.
Merge Labs is a research lab with the long-term mission of bridging biological and artificial intelligence to maximize human ability, agency and experience. Join us: merge.io/careers
Vivodyne builds lifelike, lab-grown human tissues and runs AI-driven, robotic, high-throughput preclinical testing to generate multimodal human data (imaging, single-cell transcriptomics, proteomics). Their platform aims to replace animal models by producing predictive human physiological insights at scale, accelerating therapeutic discovery and improving the selection of drug candidates before clinical trials.
Fortis partners with diagnostics and life sciences companies to design, validate, and manufacture solutions to solve their complex development problems. Fortis’ tailored approach and end-to-end capabilities accelerate the work of its customers as they bring the next generation of medicines and diagnostics to market. Fortis serves a global customer base and has offices across the world including four R&D sites...
Kailera is an advanced clinical-stage biotechnology company focused on obesity care. It is developing a diversified pipeline of GLP-1 therapies and other obesity-management medications intended to provide treatment options for people living with obesity across their treatment journeys. The company’s team has experience developing and commercializing therapies for metabolic diseases, and its clinical-stage candidates use multiple GLP-1 mechanisms and routes...
Meissner manufactures advanced microfiltration and single-use systems. Focused on fluid technology and innovation, we leverage our R&D efforts to offer our clients products that deliver advanced processing and fluid handling solutions for pharmaceutical and biopharmaceutical manufacturing. To find out more about Meissner, visit www.meissner.com. If you are interested in pursuing a career at Meissner, please visit www.meissner.com/careers.
Cellectis is a global, clinical-stage biopharmaceutical company. As pioneers and innovators in our field, we are driven by a single mission: to develop breakthrough treatments for patients with unmet medical needs. With 26 years of expertise, we operate a best-in-class genome editing platform focused on immuno-oncology and gene therapy. By leveraging our proprietary gene-editing technologies, we engineer allogeneic CAR-T cells designed...
Larimar Therapeutics is a clinical-stage biotechnology company focused on developing treatments for complex rare diseases.
ClearNote Health – Cancer detection company enabling people at risk for high-mortality cancers to live longer, healthier lives. We focus on developing non-invasive tests to detect cancer through a standard blood draw earlier than existing methods by harnessing the power of epigenomics. We apply our proprietary epigenomic platform, combining biology and artificial intelligence, to identify DNA-based changes in biology as cancer...
